Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02891161
Title Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
Acronym DUART
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Monika Joshi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.